US Stock MarketDetailed Quotes

EVOK Evoke Pharma

Watchlist

4.5916
+0.0316+0.69%

Trading Nov 21 13:42 ET

6.82MMarket Cap-453P/E (TTM)

Evoke Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

21.40%-818.7K

31.98%-820.62K

-58.16%-2.58M

24.42%-4.98M

55.87%-1.11M

5.39%-1.04M

12.18%-1.21M

-0.98%-1.63M

46.60%-6.6M

-25.49%-2.51M

Net income from continuing operations

22.52%-1.31M

32.16%-1.27M

29.57%-1.58M

5.25%-7.79M

-10.21%-1.99M

15.89%-1.69M

16.36%-1.87M

-3.19%-2.24M

3.68%-8.22M

-7.82%-1.8M

Other non cash items

-23.85%126.03K

-23.62%124.66K

-22.56%124.66K

248.61%129.07K

-1,566.04%-360.6K

--165.5K

--163.21K

--160.96K

135.22%37.03K

--24.6K

Change In working capital

15.14%236.08K

-10.46%195.37K

-927.09%-1.38M

1,070.72%1.55M

188.69%960.26K

-62.36%205.04K

-55.72%218.19K

-6.16%166.64K

102.36%132.41K

-33.82%-1.08M

-Change in receivables

90.71%-19.52K

-63.77%-551.1K

-1,146.73%-778.83K

85.37%-48.24K

1,018.58%560.83K

32.08%-210.09K

-731.74%-336.51K

49.51%-62.47K

-21.24%-329.64K

168.66%50.14K

-Change in inventory

484.47%51.36K

129.57%44.01K

-41.66%-106.94K

-85.34%-192.46K

--23.09K

--8.79K

---148.85K

---75.49K

-595.77%-103.84K

----

-Change in prepaid assets

-7.88%227.49K

-0.04%299.92K

-21.14%222.05K

209.33%31.93K

13.24%-796.62K

-28.11%246.95K

-5.75%300.04K

23.98%281.57K

-118.53%-29.21K

-2.21%-918.18K

-Change in payables and accrued expense

-111.69%-23.25K

-8.94%402.54K

-1,277.04%-714.53K

198.67%1.89M

1,476.47%1.19M

-61.97%198.87K

264.96%442.07K

-18.18%60.71K

111.44%632.12K

-160.97%-86.19K

-Change in other current liabilities

--0

-248.61%-129.07K

45.64%-13.37K

-217.61%-39.47K

---38.56K

---37.68K

---37.03K

---24.6K

Cash from discontinued investing activities

Operating cash flow

21.40%-818.7K

31.98%-820.62K

-58.16%-2.58M

24.42%-4.98M

55.87%-1.11M

5.39%-1.04M

12.18%-1.21M

-0.98%-1.63M

46.60%-6.6M

-25.49%-2.51M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

2.98M

295.7K

7.54M

-101.64%-119.3K

-119.3K

-45.68%7.29M

Net common stock issuance

---191

---1

--6.72M

--0

-49.34%7.44M

2,220.40%148.99K

Proceeds from stock option exercised by employees

--3M

--295.7K

--1.25M

----

--0

----

Net other financing activities

---15.5K

--0

---426.29K

19.93%-119.3K

----

88.64%-148.99K

----

Cash from discontinued financing activities

Financing cash flow

--2.98M

--295.7K

--7.54M

-101.64%-119.3K

---119.3K

--0

-45.68%7.29M

--0

Net cash flow

Beginning cash position

30.99%9.18M

18.14%9.7M

-51.85%4.74M

7.64%9.84M

-51.70%5.96M

-47.91%7.01M

6.64%8.21M

7.64%9.84M

13.33%9.14M

10.84%12.35M

Current changes in cash

307.49%2.16M

56.49%-524.92K

404.33%4.96M

-830.24%-5.1M

51.11%-1.23M

5.39%-1.04M

-120.98%-1.21M

-12.98%-1.63M

-35.02%698.99K

-25.49%-2.51M

End cash Position

90.10%11.34M

30.99%9.18M

18.14%9.7M

-51.85%4.74M

-51.70%5.96M

-47.91%7.01M

6.64%8.21M

7.64%9.84M

Free cash flow

21.40%-818.7K

31.98%-820.62K

-58.16%-2.58M

24.42%-4.98M

55.87%-1.11M

5.39%-1.04M

12.18%-1.21M

-0.98%-1.63M

46.60%-6.6M

-25.49%-2.51M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	21.40%-818.7K	31.98%-820.62K	-58.16%-2.58M	24.42%-4.98M	55.87%-1.11M	5.39%-1.04M	12.18%-1.21M	-0.98%-1.63M	46.60%-6.6M	-25.49%-2.51M
Net income from continuing operations	22.52%-1.31M	32.16%-1.27M	29.57%-1.58M	5.25%-7.79M	-10.21%-1.99M	15.89%-1.69M	16.36%-1.87M	-3.19%-2.24M	3.68%-8.22M	-7.82%-1.8M
Other non cash items	-23.85%126.03K	-23.62%124.66K	-22.56%124.66K	248.61%129.07K	-1,566.04%-360.6K	--165.5K	--163.21K	--160.96K	135.22%37.03K	--24.6K
Change In working capital	15.14%236.08K	-10.46%195.37K	-927.09%-1.38M	1,070.72%1.55M	188.69%960.26K	-62.36%205.04K	-55.72%218.19K	-6.16%166.64K	102.36%132.41K	-33.82%-1.08M
-Change in receivables	90.71%-19.52K	-63.77%-551.1K	-1,146.73%-778.83K	85.37%-48.24K	1,018.58%560.83K	32.08%-210.09K	-731.74%-336.51K	49.51%-62.47K	-21.24%-329.64K	168.66%50.14K
-Change in inventory	484.47%51.36K	129.57%44.01K	-41.66%-106.94K	-85.34%-192.46K	--23.09K	--8.79K	---148.85K	---75.49K	-595.77%-103.84K	----
-Change in prepaid assets	-7.88%227.49K	-0.04%299.92K	-21.14%222.05K	209.33%31.93K	13.24%-796.62K	-28.11%246.95K	-5.75%300.04K	23.98%281.57K	-118.53%-29.21K	-2.21%-918.18K
-Change in payables and accrued expense	-111.69%-23.25K	-8.94%402.54K	-1,277.04%-714.53K	198.67%1.89M	1,476.47%1.19M	-61.97%198.87K	264.96%442.07K	-18.18%60.71K	111.44%632.12K	-160.97%-86.19K
-Change in other current liabilities	--0	--0	--0	-248.61%-129.07K	45.64%-13.37K	-217.61%-39.47K	---38.56K	---37.68K	---37.03K	---24.6K
Cash from discontinued investing activities
Operating cash flow	21.40%-818.7K	31.98%-820.62K	-58.16%-2.58M	24.42%-4.98M	55.87%-1.11M	5.39%-1.04M	12.18%-1.21M	-0.98%-1.63M	46.60%-6.6M	-25.49%-2.51M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	2.98M	295.7K	7.54M	-101.64%-119.3K	-119.3K	0	0	0	-45.68%7.29M	0
Net common stock issuance	---191	---1	--6.72M	--0	--0	--0	--0	--0	-49.34%7.44M	2,220.40%148.99K
Proceeds from stock option exercised by employees	--3M	--295.7K	--1.25M	----	----	--0	--0	--0	----	----
Net other financing activities	---15.5K	--0	---426.29K	19.93%-119.3K	----	----	----	----	88.64%-148.99K	----
Cash from discontinued financing activities
Financing cash flow	--2.98M	--295.7K	--7.54M	-101.64%-119.3K	---119.3K	--0	--0	--0	-45.68%7.29M	--0
Net cash flow
Beginning cash position	30.99%9.18M	18.14%9.7M	-51.85%4.74M	7.64%9.84M	-51.70%5.96M	-47.91%7.01M	6.64%8.21M	7.64%9.84M	13.33%9.14M	10.84%12.35M
Current changes in cash	307.49%2.16M	56.49%-524.92K	404.33%4.96M	-830.24%-5.1M	51.11%-1.23M	5.39%-1.04M	-120.98%-1.21M	-12.98%-1.63M	-35.02%698.99K	-25.49%-2.51M
End cash Position	90.10%11.34M	30.99%9.18M	18.14%9.7M	-51.85%4.74M	-51.85%4.74M	-51.70%5.96M	-47.91%7.01M	6.64%8.21M	7.64%9.84M	7.64%9.84M
Free cash flow	21.40%-818.7K	31.98%-820.62K	-58.16%-2.58M	24.42%-4.98M	55.87%-1.11M	5.39%-1.04M	12.18%-1.21M	-0.98%-1.63M	46.60%-6.6M	-25.49%-2.51M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data